Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7671
Peer-review started: April 29, 2021
First decision: May 26, 2021
Revised: June 20, 2021
Accepted: July 29, 2021
Article in press: July 29, 2021
Published online: September 16, 2021
Processing time: 134 Days and 6.5 Hours
Endoscopic retrograde cholangiopancreatography (ERCP) is the primary choice for removing common bile duct (CBD) stones in Billroth II anatomy patients. The recurrence of CBD stones is still a challenging problem.
To evaluate CBD morphology and other predictors affecting CBD stone recurrence.
A retrospective case-control analysis was performed on 138 CBD stones patients with a history of Billroth II gastrectomy, who underwent therapeutic ERCP for stone extraction at our center from January 2011 to October 2020. CBD morphology and other predictors affecting CBD stone recurrence were examined by univariate analysis and multivariate logistic regression analysis.
CBD morphology (P < 0.01) and CBD diameter ≥ 1.5 cm (odds ratio [OR] = 6.15, 95% confidence interval [CI]: 1.87-20.24, P < 0.01) were the two independent risk factors. In multivariate analysis, the recurrence rate of patients with S type was 16.79 times that of patients with straight type (OR = 16.79, 95%CI: 4.26-66.09, P < 0.01), the recurrence rate of patients with polyline type was 4.97 times that of patients with straight type (OR = 4.97, 95%CI: 1.42-17.38, P = 0.01), and the recurrence rate of S type patients was 3.38 times that of patients with polyline type (OR = 3.38, 95%CI: 1.07-10.72, P = 0.04).
CBD morphology, especially S type and polyline type, is associated with increased recurrence of CBD stones in Billroth II anatomy patients.
Core Tip: Common bile duct (CBD) stone recurrence in Billroth II anatomy patients is challenging, and CBD morphology had never been noticed as a potential risk factor for CBD stone recurrence. In this study, CBD morphology was identified to be the independent risk factor for CBD stone recurrence in Billroth II anatomy patients. S type and polyline type were associated with an increased risk of recurrent CBD stones. Periodic surveillance and prophylactic therapy is recommended for Billroth II anatomy patients with S type and polyline type after successful endoscopic retrograde cholangiopancreatography.
